X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (897) 897
Book Review (240) 240
Publication (97) 97
Book / eBook (52) 52
Magazine Article (9) 9
Book Chapter (4) 4
Conference Proceeding (4) 4
Dissertation (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (883) 883
index medicus (816) 816
male (631) 631
female (546) 546
adult (370) 370
cancer (368) 368
middle aged (348) 348
anus neoplasms - virology (281) 281
anal cancer (266) 266
oncology (255) 255
human papillomavirus (254) 254
anus neoplasms - prevention & control (253) 253
anus neoplasms - epidemiology (235) 235
aged (224) 224
risk factors (208) 208
anus neoplasms - pathology (196) 196
prevalence (179) 179
anus neoplasms - diagnosis (168) 168
papillomavirus infections - prevention & control (165) 165
papillomavirus infections - complications (164) 164
papillomavirus infections (159) 159
surgery (157) 157
papillomavirus infections - epidemiology (155) 155
hiv (153) 153
hiv infections - complications (137) 137
infectious diseases (133) 133
cervical cancer (129) 129
men (129) 129
adolescent (126) 126
young adult (123) 123
anus neoplasms - therapy (121) 121
anus (118) 118
incidence (118) 118
human-papillomavirus infection (113) 113
papillomavirus infections - virology (113) 113
women (112) 112
diagnosis (111) 111
health aspects (111) 111
prevention (110) 110
infection (109) 109
homosexuality, male (105) 105
hpv (105) 105
abridged index medicus (101) 101
squamous intraepithelial lesions (101) 101
risk (100) 100
research (96) 96
neoplasia (89) 89
aged, 80 and over (87) 87
epidemiology (85) 85
lesions (85) 85
retrospective studies (85) 85
carcinoma (84) 84
vaccination (84) 84
carcinoma, squamous cell - pathology (83) 83
immunology (83) 83
squamous-cell carcinoma (83) 83
anus neoplasms - etiology (81) 81
care and treatment (81) 81
intraepithelial neoplasia (81) 81
medicine & public health (81) 81
united-states (79) 79
sex (78) 78
anal canal - pathology (77) 77
uterine cervical neoplasms - prevention & control (77) 77
aids/hiv (76) 76
anus neoplasms - surgery (75) 75
human immunodeficiency virus--hiv (75) 75
papillomavirus infections - diagnosis (74) 74
gastroenterology & hepatology (73) 73
human-papillomavirus (73) 73
squamous cell carcinoma (72) 72
cervical-cancer (71) 71
rectum (71) 71
treatment outcome (71) 71
papillomaviridae - isolation & purification (70) 70
carcinoma, squamous cell - virology (68) 68
vaccines (68) 68
carcinoma, squamous cell - epidemiology (67) 67
risk-factors (66) 66
uterine cervical neoplasms - virology (66) 66
papillomavirus vaccines - administration & dosage (65) 65
radiotherapy (65) 65
analysis (64) 64
anus neoplasms (64) 64
infections (64) 64
article (62) 62
active antiretroviral therapy (59) 59
papillomavirus vaccines (59) 59
public, environmental & occupational health (59) 59
sexual behavior (59) 59
united states - epidemiology (59) 59
anal intraepithelial neoplasia (58) 58
child (58) 58
dysplasia (58) 58
uterine cervical neoplasms - epidemiology (58) 58
aids (57) 57
anus neoplasms - complications (57) 57
prognosis (57) 57
anal canal - virology (56) 56
human-immunodeficiency-virus (56) 56
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (903) 903
French (17) 17
German (13) 13
Spanish (8) 8
Czech (4) 4
Portuguese (4) 4
Russian (4) 4
Italian (2) 2
Polish (2) 2
Danish (1) 1
Hebrew (1) 1
Hungarian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the National Cancer Institute, ISSN 0027-8874, 02/2013, Volume 105, Issue 3, pp. 175 - 201
The American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American... 
United States - epidemiology | Age Distribution | Asian Americans - statistics & numerical data | Humans | Uterine Cervical Neoplasms - epidemiology | Cost of Illness | Anus Neoplasms - virology | Hispanic Americans - statistics & numerical data | Male | Neoplasms - prevention & control | Cause of Death | Incidence | Indians, North American - statistics & numerical data | Penile Neoplasms - epidemiology | Neoplasms - virology | Neoplasms - ethnology | Female | Anus Neoplasms - epidemiology | Papillomavirus Vaccines - administration & dosage | Penile Neoplasms - virology | Papillomavirus Infections - complications | SEER Program | Papanicolaou Test | Papillomavirus Infections - epidemiology | Neoplasms - mortality | Papillomavirus Infections - ethnology | Vulvar Neoplasms - virology | Mortality - trends | Oropharyngeal Neoplasms - virology | Vaginal Neoplasms - virology | Vaginal Smears - statistics & numerical data | Alphapapillomavirus | Oropharyngeal Neoplasms - epidemiology | African Americans - statistics & numerical data | Oceanic Ancestry Group - statistics & numerical data | Vaginal Neoplasms - epidemiology | Adolescent | Vulvar Neoplasms - epidemiology | Sex Distribution | Uterine Cervical Neoplasms - virology | Neoplasms - epidemiology | Prevention | Control | Forecasts and trends | Papillomavirus infections | Patient outcomes | Mortality | Index Medicus
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2015, Volume 51, Issue 13, pp. 1732 - 1741
Abstract Objective Human papillomavirus (HPV) vaccines can potentially control cervical cancer and help to reduce other HPV-related cancers. We aimed to... 
Hematology, Oncology and Palliative Medicine | Papillomavirus vaccines | Human papillomavirus | Vulvar neoplasms | Vaginal neoplasms | Uterine cervical neoplasms | Precancerous conditions | Anus neoplasms | INFECTIONS | Uterine cervical neo-plasms | VACCINE | PREVALENCE | INTRAEPITHELIAL NEOPLASIA | WORLDWIDE | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | INVASIVE CERVICAL-CANCER | VULVA | Predictive Value of Tests | Age Distribution | Age Factors | Humans | Middle Aged | Anus Neoplasms - prevention & control | Anus Neoplasms - virology | Papillomaviridae - genetics | Papillomavirus Infections - diagnosis | Uterine Cervical Dysplasia - diagnosis | Young Adult | Papillomaviridae - immunology | Uterine Cervical Dysplasia - virology | Vaginal Neoplasms - prevention & control | Aged, 80 and over | Adult | Female | Papillomavirus Infections - virology | Vulvar Neoplasms - diagnosis | Retrospective Studies | Uterine Cervical Neoplasms - diagnosis | Cross-Sectional Studies | Uterine Cervical Neoplasms - prevention & control | Cervical Intraepithelial Neoplasia - diagnosis | Vulvar Neoplasms - virology | Uterine Cervical Dysplasia - prevention & control | Vaginal Neoplasms - virology | Cervical Intraepithelial Neoplasia - virology | Anus Neoplasms - diagnosis | Papillomavirus Infections - prevention & control | Papillomaviridae - classification | Vulvar Neoplasms - prevention & control | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Papillomavirus Vaccines - immunology | Aged | Human Papillomavirus DNA Tests | DNA, Viral - genetics | Vaginal Neoplasms - diagnosis | Papillomaviruses | Genetic aspects | Papillomavirus infections | Cervical cancer | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2008, Volume 359, Issue 8, pp. 821 - 832
Journal Article
BMC Cancer, ISSN 1471-2407, 01/2013, Volume 13, Issue 1, pp. 10 - 10
Background: HPV is related to a number of cancer types, causing a considerable burden in both genders in Europe. Female vaccination programs can substantially... 
HPV-related cancer | Genital warts | Human papillomavirus | HPV-related disease | Vaccination | Cervical cancer | UNITED-STATES | METAANALYSIS | MANAGEMENT | CANCERS | FRANCE | IMPACT | ONCOLOGY | HUMAN-PAPILLOMAVIRUS VACCINES | BURDEN | CARCINOMA | Human papillomavirus 18 - immunology | Head and Neck Neoplasms - virology | Human papillomavirus 6 - immunology | Humans | Condylomata Acuminata - virology | Genital Neoplasms, Female - prevention & control | Anus Neoplasms - prevention & control | Anus Neoplasms - virology | Male | Human papillomavirus 16 - immunology | Condylomata Acuminata - prevention & control | Incidence | Papillomaviridae - immunology | Condylomata Acuminata - immunology | Penile Neoplasms - immunology | Papillomavirus Infections - immunology | Female | Papillomavirus Infections - virology | Human papillomavirus 11 - immunology | Child | Papillomavirus Vaccines - administration & dosage | Papillomavirus Infections - transmission | Penile Neoplasms - virology | Head and Neck Neoplasms - prevention & control | Penile Neoplasms - prevention & control | Papillomavirus Infections - epidemiology | Europe - epidemiology | Genital Neoplasms, Female - immunology | Genital Neoplasms, Female - virology | Head and Neck Neoplasms - immunology | Anus Neoplasms - immunology | Papillomavirus Infections - prevention & control | Program Evaluation | Prevention | Research | Demographic aspects | Papillomavirus infections | Warts | Medical research | Medicine, Experimental | Epidemiology | Cancer | Index Medicus
Journal Article
Vaccine, ISSN 0264-410X, 11/2017, Volume 35, Issue 46, pp. 6329 - 6335
Estonia has high cervical cancer incidence and low screening coverage. We modelled the impact of population-based bivalent, quadrivalent or nonavalent HPV... 
Genital warts | Cost-effectiveness | Vaccination | Cervical cancer | HPV | MEDICINE, RESEARCH & EXPERIMENTAL | COUNTRIES | IMMUNOLOGY | WOMEN | TRANSMISSION | MEN | INFECTION | BURDEN | HUMAN-PAPILLOMAVIRUS-VACCINATION | QUADRIVALENT | VACCINES | Estonia - epidemiology | Humans | Middle Aged | Uterine Cervical Neoplasms - epidemiology | Anus Neoplasms - prevention & control | Incidence | Young Adult | Vaginal Neoplasms - prevention & control | Aged, 80 and over | Uterine Cervical Neoplasms - economics | Adult | Female | Anus Neoplasms - epidemiology | Oropharyngeal Neoplasms - economics | Child | Papillomavirus Vaccines - administration & dosage | Mouth Neoplasms - prevention & control | Papillomavirus Infections - complications | Papillomavirus Vaccines - economics | Papillomavirus Infections - epidemiology | Uterine Cervical Neoplasms - prevention & control | Mouth Neoplasms - economics | Models, Statistical | Mouth Neoplasms - epidemiology | Oropharyngeal Neoplasms - epidemiology | Vaginal Neoplasms - epidemiology | Papillomavirus Infections - prevention & control | Cost-Benefit Analysis | Adolescent | Vaginal Neoplasms - economics | Oropharyngeal Neoplasms - prevention & control | Papillomavirus Vaccines - immunology | Aged | Anus Neoplasms - economics | Medical research | Analysis | Medicine, Experimental | Diagnosis | Cancer | Health insurance | Immunization | Sensitivity analysis | Mortality | Vagina | Infections | Vaccines | Cervix | Cost benefit analysis | Medical screening | Immunity | Girls | Cancer vaccines | Warts | Screening | Human papillomavirus | Utilities | Markov models | Lesions | Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 9, pp. 862 - 870
Summary Background Anal cancer remains rare (incidence of about 1·5 per 100 000 women yearly), but rates are increasing in many countries. Human papillomavirus... 
Hematology, Oncology and Palliative Medicine | BROAD-SPECTRUM | QUADRIVALENT VACCINE | ASSAY | ONCOLOGY | PARTICLE VACCINE | PREVENTION | HUMAN-PAPILLOMAVIRUS | CANCER | CARCINOMA | PCR | EPIDEMIOLOGY | Human papillomavirus 18 - immunology | Precancerous Conditions - epidemiology | Adjuvants, Immunologic - administration & dosage | Prevalence | Humans | Lipid A - analogs & derivatives | Uterine Cervical Neoplasms - epidemiology | Anus Neoplasms - prevention & control | Anus Neoplasms - virology | Aluminum Hydroxide - administration & dosage | Human papillomavirus 16 - immunology | Young Adult | Precancerous Conditions - virology | Time Factors | Adult | Female | Immunization Schedule | Papillomavirus Infections - virology | Anus Neoplasms - epidemiology | Papillomavirus Vaccines - administration & dosage | Lipid A - administration & dosage | Double-Blind Method | Risk Assessment | Papillomavirus Infections - epidemiology | Risk Factors | Uterine Cervical Neoplasms - prevention & control | Treatment Outcome | Chi-Square Distribution | Papillomavirus Infections - prevention & control | Adolescent | Costa Rica - epidemiology | Uterine Cervical Neoplasms - virology | Precancerous Conditions - prevention & control | Clinical trials | Research | Vaccines | Papillomavirus infections | Oncology, Experimental | Cancer | Index Medicus
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 382, Issue 9895, pp. 889 - 899
Summary Cervical cancer is caused by human papillomavirus infection. Most human papillomavirus infection is harmless and clears spontaneously but persistent... 
Internal Medicine | ARTISTIC TRIAL | COSTA-RICA | WOMEN | MEDICINE, GENERAL & INTERNAL | VACCINE | POPULATION-BASED COHORT | HPV INFECTION | INDIVIDUAL DATA | FOLLOW-UP | INTRAEPITHELIAL NEOPLASIA | COLLABORATIVE REANALYSIS | Human papillomavirus 18 - immunology | Human papillomavirus 6 - immunology | Humans | Uterine Cervical Neoplasms - epidemiology | Human papillomavirus 11 - ultrastructure | Uterine Cervical Neoplasms - pathology | Human papillomavirus 16 - immunology | Human papillomavirus 6 - ultrastructure | Papillomavirus Infections - pathology | Papillomavirus Infections - immunology | Female | Papillomavirus Infections - virology | Human papillomavirus 11 - immunology | Human papillomavirus 16 - ultrastructure | Human papillomavirus 11 - pathogenicity | Papillomavirus Vaccines - administration & dosage | Human papillomavirus 6 - pathogenicity | Human papillomavirus 16 - pathogenicity | Cross-Sectional Studies | Papillomavirus Infections - epidemiology | Uterine Cervical Neoplasms - prevention & control | Uterine Cervical Neoplasms - immunology | Vaginal Smears | Mass Screening | Virus Replication | Human papillomavirus 18 - pathogenicity | Papillomavirus Infections - prevention & control | Uterine Cervical Neoplasms - virology | Human papillomavirus 18 - ultrastructure | Papillomavirus Vaccines - immunology | Developing Countries | Cell Transformation, Neoplastic - pathology | Cell Transformation, Viral | Prevention | Papillomaviruses | Usage | Vaccines | Properties | Papillomavirus infections | Risk factors | Cervical cancer | Studies | Human papillomavirus | Immunization | Cellular biology | Womens health | Medical screening | Epidemiology | Age | Index Medicus | Abridged Index Medicus
Journal Article
Sexually Transmitted Infections, ISSN 1368-4973, 11/2012, Volume 88, Issue 7, pp. 517 - 521
Objectives To obtain health-related quality of life valuations (ie, utilities) for human papillomavirus (HPV)-related cancer health states of vulval, vaginal,... 
UNITED-STATES | HEAD | INFECTIOUS DISEASES | LONG-TERM SURVIVORS | OROPHARYNX | MANAGEMENT | SQUAMOUS-CELL CARCINOMA | RADIOTHERAPY | BURDEN | NECK-CANCER | EPIDEMIOLOGY | Vaginal Neoplasms - psychology | Humans | Middle Aged | Anus Neoplasms - prevention & control | Anus Neoplasms - virology | Male | Oropharyngeal Neoplasms - psychology | Oropharyngeal Neoplasms - pathology | Anus Neoplasms - psychology | Young Adult | Vulvar Neoplasms - pathology | Penile Neoplasms - pathology | Penile Neoplasms - psychology | Vaginal Neoplasms - prevention & control | Adult | Female | Surveys and Questionnaires | Penile Neoplasms - virology | Papillomavirus Infections - complications | Penile Neoplasms - prevention & control | Vaginal Neoplasms - pathology | Vulvar Neoplasms - virology | Anus Neoplasms - pathology | Oropharyngeal Neoplasms - virology | Patient Acceptance of Health Care - statistics & numerical data | Health Knowledge, Attitudes, Practice | Vaginal Neoplasms - virology | Papillomavirus Infections - prevention & control | Vulvar Neoplasms - prevention & control | Adolescent | Quality of Life | Oropharyngeal Neoplasms - prevention & control | Aged | Vulvar Neoplasms - psychology | Papillomaviruses | Prevention | Causes of | Host-virus relationships | Health aspects | Papillomavirus infections | Risk factors | Quality of life | Studies | Human papillomavirus | Cervical cancer | Index Medicus | oral sex | attitudes | oral cavity | Anogenital cancer | Health Services Research | 1506 | oncology | HPV | vaccination
Journal Article
Sexual Health, ISSN 1448-5028, 2010, Volume 7, Issue 3, pp. 244 - 252
Although the human papillomavirus (HPV) vaccine was introduced primarily as a cervical cancer prevention vaccine, HPV has a causal role in several types of... 
Australia | HPV vaccine | cervical cancer | UNITED-STATES | INFECTIOUS DISEASES | METAANALYSIS | PREVENTION | CERVICAL-CANCER | PREVALENCE | INTRAEPITHELIAL NEOPLASIA | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | ANAL CANCER | SEXUAL PRACTICES | SQUAMOUS-CELL CARCINOMAS | PENILE CANCER | Age Factors | Humans | Middle Aged | Uterine Cervical Neoplasms - epidemiology | Anus Neoplasms - prevention & control | Male | Human papillomavirus 18 | Incidence | Penile Neoplasms - epidemiology | Young Adult | Human papillomavirus 16 | Sexually Transmitted Diseases, Viral - epidemiology | Vaginal Neoplasms - prevention & control | Adult | Female | Anus Neoplasms - epidemiology | Cervical Intraepithelial Neoplasia - epidemiology | Child | Papillomavirus Vaccines - administration & dosage | Cross-Sectional Studies | Carcinoma, Squamous Cell - epidemiology | Papanicolaou Test | Penile Neoplasms - prevention & control | Papillomavirus Infections - epidemiology | Uterine Cervical Neoplasms - prevention & control | Vaginal Smears | Carcinoma, Squamous Cell - prevention & control | Oropharyngeal Neoplasms - epidemiology | Vaginal Neoplasms - epidemiology | Cross-Cultural Comparison | Papillomavirus Infections - prevention & control | Vulvar Neoplasms - prevention & control | Adolescent | Sex Factors | Sexually Transmitted Diseases, Viral - prevention & control | Vulvar Neoplasms - epidemiology | Cervical Intraepithelial Neoplasia - prevention & control | Oropharyngeal Neoplasms - prevention & control | Aged | Developing Countries | Population Surveillance
Journal Article